Analyst Research

Report Title Price
Provider: Sadif Analytics (Premium)
Provider: Finlabo SIM Spa
Provider: Reuters Investment Profile
Provider: MarketLine (a Datamonitor Company)

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Fresenius SE & Co KGaA To Quit Biotech Unit-Reuters

Friday, 14 Dec 2012 02:15am EST 

Reuters reported that Fresenius SE & Co KGaA will exit its loss-making biotech business in order to focus on its other businesses. Fresenius said it was in talks with several parties over a sale of Fresenius Biotech, which had sales of EUR26 million ($34 million) in the first nine months of 2012 but posted a loss of EUR15 million. 

Company Quote

-0.55 -0.49%
11:35am EDT